ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start
Launched by OREGON RESEARCH INSTITUTE · Nov 23, 2021
Trial Information
Current as of May 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a program called Mom-Net, which is an online therapy designed to help mothers who are feeling depressed. Many low-income women who have children are at a higher risk of experiencing depression but often don’t get the help they need. Mom-Net provides cognitive behavioral therapy (CBT) online, along with live coaching to support mothers as they learn to manage their symptoms and improve their parenting skills. The study aims to see if this program can be effectively offered through Head Start agencies, which help prepare children for school, and whether it helps reduce depression in mothers.
To be eligible for this trial, mothers need to be experiencing elevated symptoms of depression and have a child aged 2 to 5 who is enrolled in a participating Head Start program. During the study, mothers will be randomly assigned to either receive the Mom-Net program or the usual treatment, which usually involves being referred to community mental health providers. They will take part in assessments before starting the program, after completing it, and again a year later to see how they and their children are doing. This trial is currently recruiting participants and aims to improve access to mental health support for mothers in need.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: Mothers
- • Elevated symptoms of depression (i.e., Patient Health Questionnaire or Edinburgh Postnatal Depression Scale score at or above 10)
- • Have a child 2-5 years enrolled in a participating Head Start; be able to communicate in English or Spanish.
- • Inclusion Criteria: Child
- • - 2-5 years of age and enrolled in participation Head Start
- • Exclusion Criteria: Mothers
- • Evidence of psychosis or other major mental illness or cognitive disability (observed during recruitment or by HS report) that would interfere with meaningful participation
- • Endorsed score of 3 on final item of the PHQ9 or EPDS indicating frequent thoughts of suicide. Could be enrolled at later date if elevated risk ameliorates
- • Exclusion Criteria: Children
- • No exclusion criteria
About Oregon Research Institute
The Oregon Research Institute (ORI) is a leading nonprofit organization dedicated to advancing scientific knowledge and improving public health through innovative research. With a focus on behavioral and mental health, ORI conducts rigorous clinical trials aimed at developing effective interventions and programs. The institute is committed to a multidisciplinary approach, leveraging expertise in psychology, neuroscience, and public health to address complex health challenges. Through collaboration with academic, clinical, and community partners, ORI strives to translate research findings into practical solutions that enhance the well-being of individuals and communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Eugene, Oregon, United States
Springfield, Oregon, United States
Patients applied
Trial Officials
Edward G Feil, Ph.D.
Principal Investigator
Oregon Research Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials